Immunohistochemistry studies extended to HBL tumor tissue from subjects treated with surgical resection or transplantation confirm that aberrant EGFR-ASAP1 signaling is associated with loss of differentiation and increased invasiveness in HBL. This evidence concerns the gene EGFR and neoplasm.